Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

320 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL.
Kebriaei P, Madden T, Wang X, Thall PF, Ledesma C, de Lima M, Shpall EJ, Hosing C, Qazilbash M, Popat U, Alousi A, Nieto Y, Champlin RE, Jones RB, Andersson BS. Kebriaei P, et al. Among authors: qazilbash m. Bone Marrow Transplant. 2013 Jan;48(1):26-31. doi: 10.1038/bmt.2012.114. Epub 2012 Jun 25. Bone Marrow Transplant. 2013. PMID: 22732703 Free PMC article. Clinical Trial.
High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age.
Hosing C, Saliba RM, Okoroji GJ, Popat U, Couriel D, Ali T, De Padua Silva L, Kebriaei P, Alousi A, De Lima M, Qazilbash M, Anderlini P, Giralt S, Champlin RE, Khouri I. Hosing C, et al. Among authors: qazilbash m. Ann Oncol. 2008 Jun;19(6):1166-71. doi: 10.1093/annonc/mdm608. Epub 2008 Feb 13. Ann Oncol. 2008. PMID: 18272911 Free PMC article.
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.
Ciurea SO, Saliba R, Rondon G, Pesoa S, Cano P, Fernandez-Vina M, Qureshi S, Worth LL, McMannis J, Kebriaei P, Jones RB, Korbling M, Qazilbash M, Shpall EJ, Giralt S, de Lima M, Champlin RE, Gajewski J. Ciurea SO, et al. Among authors: qazilbash m. Bone Marrow Transplant. 2010 Mar;45(3):429-36. doi: 10.1038/bmt.2009.189. Epub 2009 Aug 10. Bone Marrow Transplant. 2010. PMID: 19668237 Free PMC article. Clinical Trial.
Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR.
Popat U, de Lima MJ, Saliba RM, Anderlini P, Andersson BS, Alousi AM, Hosing C, Nieto Y, Parmar S, Khouri IF, Kebriaei P, Qazilbash M, Champlin RE, Giralt SA. Popat U, et al. Among authors: qazilbash m. Bone Marrow Transplant. 2012 Feb;47(2):212-6. doi: 10.1038/bmt.2011.61. Epub 2011 Mar 21. Bone Marrow Transplant. 2012. PMID: 21423123 Free PMC article.
Clofarabine combined with busulfan provides excellent disease control in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.
Kebriaei P, Basset R, Ledesma C, Ciurea S, Parmar S, Shpall EJ, Hosing C, Khouri I, Qazilbash M, Popat U, Alousi A, Nieto Y, Jones RB, de Lima M, Champlin RE, Andersson BS. Kebriaei P, et al. Among authors: qazilbash m. Biol Blood Marrow Transplant. 2012 Dec;18(12):1819-26. doi: 10.1016/j.bbmt.2012.06.010. Epub 2012 Jun 29. Biol Blood Marrow Transplant. 2012. PMID: 22750645 Free PMC article. Clinical Trial.
Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia.
Poon LM, Bassett R Jr, Rondon G, Hamdi A, Qazilbash M, Hosing C, Jones RB, Shpall EJ, Popat UR, Nieto Y, Worth LL, Cooper L, De Lima M, Champlin RE, Kebriaei P. Poon LM, et al. Among authors: qazilbash m. Bone Marrow Transplant. 2013 May;48(5):666-70. doi: 10.1038/bmt.2012.195. Epub 2012 Oct 22. Bone Marrow Transplant. 2013. PMID: 23085830 Free PMC article.
Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution.
Hosing C, Bassett R, Dabaja B, Talpur R, Alousi A, Ciurea S, Popat U, Qazilbash M, Shpall EJ, Oki Y, Nieto Y, Pinnix C, Fanale M, Maadani F, Donato M, Champlin R, Duvic M. Hosing C, et al. Among authors: qazilbash m. Ann Oncol. 2015 Dec;26(12):2490-5. doi: 10.1093/annonc/mdv473. Epub 2015 Sep 28. Ann Oncol. 2015. PMID: 26416896 Free PMC article. Clinical Trial.
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome.
de Lima M, Champlin RE, Thall PF, Wang X, Martin TG 3rd, Cook JD, McCormick G, Qazilbash M, Kebriaei P, Couriel D, Shpall EJ, Khouri I, Anderlini P, Hosing C, Chan KW, Andersson BS, Patah PA, Caldera Z, Jabbour E, Giralt S. de Lima M, et al. Among authors: qazilbash m. Leukemia. 2008 Feb;22(2):258-64. doi: 10.1038/sj.leu.2405014. Epub 2007 Nov 8. Leukemia. 2008. PMID: 17989720 Clinical Trial.
Long-term outcomes of Sleeping Beauty-generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas.
Srour SA, Singh H, McCarty J, de Groot E, Huls H, Rondon G, Qazilbash M, Ciurea S, Bardelli G, Buck J, Alousi A, Nieto Y, Rezvani K, Marin D, Popat U, Hosing C, Shpall EJ, Wierda WG, Kantarjian H, Champlin RE, Cooper LJ, Kebriaei P. Srour SA, et al. Among authors: qazilbash m. Blood. 2020 Mar 12;135(11):862-865. doi: 10.1182/blood.2019002920. Blood. 2020. PMID: 31961918 Free PMC article. No abstract available.
Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation.
Oran B, Giralt S, Couriel D, Hosing C, Shpall EJ, de Meis E, Khouri IF, Qazilbash M, Anderlini P, Kebriaei P, Popat U, Carrasco-Yalan A, Champlin RE, de Lima M. Oran B, et al. Among authors: qazilbash m. Leukemia. 2007 Dec;21(12):2540-4. doi: 10.1038/sj.leu.2404828. Epub 2007 Jul 5. Leukemia. 2007. PMID: 17611563 No abstract available.
320 results